Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting: A Randomized Double-Blind Trial

NCT05640453 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT05640453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05640453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting: A Randomized Double-Blind Trial
Lead sponsor
Tanta University
Phase
Phase 4
Overall status
Recruiting
Start date
December 15, 2022
Completion date
May 15, 2026
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass grafting, delirium treatment, dexmedetomidine, pregabalin